Hope on the Horizon: Trials, Treatments and Therapies for DMD, DM1 & MG
Muscular Dystrophy Canada in partnership with the Neuromuscular Disease Network for Canada’s Clinical Trial Network is excited to host three Hope on the Horizon events!
These webinars are geared towards family members and people living with NMDs.
Join us to learn more about the treatment and clinical trial landscape for Duchenne Muscular Dystrophy, Myotonic Dystrophy Type 1 and Myasthenia Gravis from key experts in the field!
Learn More and Register:
- Nov 26, 2025: Duchenne Muscular Dystrophy
- Nov 27, 2025: Myotonic Dystrophy Type 1
- Nov 28, 2025: Myasthenia Gravis
Post-Event Update
Click to watch the webinars on MDC’s YouTube Channel.
Read next...
New Standard Operating Procedure: Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers
We are excited to announce the release of our latest Standard Operating Procedure (SOP) titled “Measurement and Analysis of Mitochondrial Function In Situ in Permeabilized Muscle Fibers”, developed by our BSTC members Dr. Sean Ng and Magda Lensinski.
NMD4C Hosts 2nd Annual Clinical Summer School at the University of Calgary!
On 24 September 2026, our second annual NMD4C Clinical Summer School brought together 25 neuromuscular fellows from across Canada to the University of Calgary for a day of hands-on learning, discussion, connection, and collaboration.
2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!
Deadline: December 1, 2026
2027 NMD4C–RARE.Qc Basic Science Research Summer School Applications Are Now Open!
The summer school offers neuromuscular and rare disease research trainees the opportunity to participate in an intensive three-day training program focused on cutting-edge experimental and translational research techniques.